From: chemistry-request at ccl.net <br />
To: chemistry-request at ccl.net<br />
Date: Wed Feb  4 14:56:39 2009<br />
Subject: 09.06.04 <span class="fancysmall">CHI&#39;s Structure-Based Drug Design</span><br />

<pre>Dates: June 4-5,2009
Venue: Royal Sonesta Hotel, Cambridge, Massachusetts USA

Topics of discussion include:
- Target Structure-Guided Drug Discovery
- Feeding SBDD with Biochemical and Biophysical Information
- Ligand-Based Predictions Applied to Drug Design
- SBDD and Computational Chemistry Methods: A Marriage of Innovation
- SBDD of Pharmacological Chaperons

Distinguished Faculty:
Alex Aronov, Ph.D., Vertex Pharmaceuticals, Inc.

Xavier Barril, Ph.D. , ICREA Research Universitat de Barcelona

Alex Burgin, Ph.D., deCODE Biostructures

Miles Congreve, Ph.D., Heptares Therapeutics Ltd.

Jos&Atilde;&copy; Duca, Ph.D., Schering Plough Research Institute

Stefan Geschwindner, Ph.D., AstraZeneca R&amp;D M&Atilde;&para;lndal

Ajay N. Jain, Ph.D., University of California, San Francisco

Paul Labute, Ph.D., Computing Group (CCG)

Dr. Richard J. Law, Evotec AG

Brian B. Masek, Ph.D., Tripos International

Mark Murcko, Ph.D., Vertex Pharmaceuticals, Inc.

Sander Nabuurs, Ph.D., Radboud University Nijmegen

Enrico O. Purisima, Ph.D., National Research Council of Canada

Dagmar Ringe, Ph.D., Brandeis University

Suo-Bao Rong, Ph.D., Pfizer Global R&amp;D

Tomi Sawyer, Ph.D., AILERON Therapeutics; Editor-in-Chief, Chemical Biology &amp; Drug Design

Andrew D. Scott, Ph.D., Pfizer Global Research and Development

Suresh Singh, Ph.D., Vitae Pharmaceuticals

Raymond C. Stevens, Scripps Research Institute

Gergely Toth, Ph.D., Elan Pharmaceuticals

Marcel Verdonk, Ph.D., Astex Therapeutics, Ltd.

Markus Wagener, Ph.D., Schering-Plough Research Institute

W. Patrick Walters, Ph.D., Vertex Pharmaceuticals, Inc.

Plus! Pre-Conference Workshop, Wednesday, June 3
Designing Kinase Inhibitors*

Topics Discussed:
- Challenges of Crystal Structures
- X-Ray Crystallography
- Target Immobilized NMR Screening
*Separate registration is required.

Arrive early to attend...
Protein Kinase Targets
June 1-3
www.healthtech.com/KIN/overview.aspx

Interested in Sponsorships and Exhibit Opportunities?
Contact:
Katelin Fitzgerald
Manager, Business Development
Tel: 781-972-5458
E-mail: kfitzgerald(0)healthtech.com

Special Pricing is Available to Attend Both the Structure-Based Drug Design and Protein Kinase Conferences.

Learn more and register at www.healthtech.com/SBD/overview.aspx

Otherwise, call CHI at 781-972-5400.</pre>
<b>NOTE THAT E-MAIL ADDRESSES HAVE BEEN MODIFIED!!!</b><br />
All @ signs were changed to (0) to fight spam. Before you send e-mail, you
need to change (0) to @<br />
For example: change joe(0)big123comp.com to joe@big123comp.com<br />
<em>Please let colleagues know about conference listingts at
Computational Chemistry List Conference Page at</em>
<a href="http://www.ccl.net/chemistry/a/conferences/"
class="link">http://www.ccl.net/chemistry/a/conferences/</a>.